Related Experiment Video
Updated: May 20, 2026

09:19
RNA Catalyst as a Reporter for Screening Drugs against RNA Editing in Trypanosomes
Published on: July 22, 2014
A strategy for developing a hammerhead ribozyme for selective RNA cleavage depending on substitutional RNA editing
Masatora Fukuda1, Kei Kurihara, Yasuyoshi Tanaka
1Department of Chemistry, Faculty of Science, Fukuoka University, Jonan-ku, Fukuoka 814-0180, Japan. masatora@fukuoka-u.ac.jp
Summary
Researchers developed a new hammerhead ribozyme strategy for targeted RNA cleavage at specific substitutional RNA editing sites. This method enables precise recognition and cleavage of adenosine to inosine (A-to-I) and cytosine to uracil (C-to-U) edits in RNA molecules.
Area of Science:
- Molecular Biology
- Biochemistry
- RNA Therapeutics
Background:
- Substitutional RNA editing, including adenosine to inosine (A-to-I) and cytosine to uracil (C-to-U) modifications, is vital for regulating gene expression and biological functions.
- Targeted RNA cleavage is a valuable tool for studying and manipulating RNA editing processes within cells.
- Hammerhead ribozymes are efficient catalytic RNAs capable of site-specific RNA cleavage, offering potential for RNA-editing-dependent applications.
Purpose of the Study:
- To design and validate a novel hammerhead ribozyme strategy for specifically recognizing and cleaving RNA at substitutional RNA editing sites.
- To demonstrate the efficacy of this strategy for both A-to-I and C-to-U RNA editing events.
- To provide a foundation for developing RNA-editing-dependent RNA degradation systems for therapeutic or research purposes.
Main Methods:
- Designed hammerhead ribozymes engineered to recognize specific RNA editing sites by pairing with the edited base.
- Tested the A-to-I editing-specific ribozyme activity against synthetic serotonin receptor 2C mRNA fragments.
- Assessed the C-to-U editing-specific ribozyme activity against synthetic apolipoprotein B mRNA fragments.
- Validated the A-to-I editing-specific ribozyme activity on endogenous filamin A (FLNA) mRNA extracted from cells.
Main Results:
- The designed hammerhead ribozymes exhibited specific cleavage activity dependent on the presence of A-to-I and C-to-U RNA edits in vitro.
- Successful editing-specific cleavage was observed against synthetic RNA fragments mimicking known editing sites.
- The ribozyme demonstrated efficacy in cleaving physiologically edited FLNA mRNA, confirming its applicability to endogenous targets.
- The strategy proved effective for RNA cleavage in an editing-dependent manner.
Conclusions:
- A novel design strategy for hammerhead ribozymes enables specific recognition and cleavage of A-to-I and C-to-U RNA editing sites.
- This approach provides a powerful tool for analyzing and potentially manipulating RNA editing processes.
- The findings support the potential application of these ribozymes for RNA-editing-dependent RNA degradation in vivo.
Related Concept Videos
RNA Editing
RNA editing is a post-transcriptional modification where a precursor mRNA (pre-mRNA) nucleotide sequence is changed by base insertion, deletion, or modification. The extent of RNA editing varies from a few hundred bases, in mitochondrial DNA of trypanosomes, to a just single base, in nuclear genes of mammals. Even a single base change in the pre-mRNA can convert a codon for one amino acid into the codon for another amino acid or a stop codon. This type of re-coding can significantly affect the...
Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...
Ribozymes
The term ribozyme is used for RNA that can act as an enzyme. Ribozymes are mainly found in selected viruses, bacteria, plant organelles, and lower eukaryotes. Ribozymes were first discovered in 1982 when Tom Cech’s laboratory observed Group I introns acting as enzymes. This was shortly followed by the discovery of another ribozyme, Ribonulcease P, by Sid Altman’s laboratory. Both Cech and Altman received the Nobel Prize in chemistry in 1989 for their work on ribozymes.
Ribozymes can be...
Ribozymes can be...
Experimental RNAi
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
RNA Interference
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Riboswitches
Riboswitches are non-coding mRNA domains that regulate the transcription and translation of downstream genes without the help of proteins. Riboswitches bind directly to a metabolite and can form unique stem-loop or hairpin structures in response to the amount of the metabolite present. They have two distinct regions – a metabolite-binding aptamer and an expression platform.
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...
The aptamer has high specificity for a particular metabolite which allows riboswitches to specifically regulate...

